Subscribe free

HPB & Spleen ·

Chronic Steroid Use Does Not Increase Morbidity After Distal Pancreatectomy

Chronic steroid use does not impact short-term complications or mortality in patients undergoing distal pancreatectomy.

  • In a study of 6,876 patients, chronic steroid users (623 patients) showed no significant differences in major complications (31.7% vs 30.1%), minor complications (42.2% vs 41.6%), or mortality (3.4% vs 3.2%) compared to non-steroid users after propensity matching.
  • Chronic steroid use should not be viewed as a contraindication to undergoing distal pancreatectomy.

Limitations include the inability to analyze dose-response relationships, so these findings should be interpreted with caution.

Journal Article by Ganguli S, Gao JZ (…) Aziz H et 2 al. in BMC Surg

Copyright © 2026 Elsevier Inc. All rights reserved.

read the whole article in BMC Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

All papers in HPB & Spleen →